ECL vs NEO · P/E 35, rev $8.48B vs rev $388.3M
Ecolab Inc (ECL) versus NeoGenomics Inc (NEO) — a side-by-side from cached financials, not a winner call.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
NeoGenomics Inc (NEO) is a diagnostics & research company listed on US.
Latest reported ECL revenue for 2026-06-30 was $8.48B. Net income was $967.5M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Latest reported NEO revenue for 2026-06-30 was $388.3M. Net income was -$14.9M. NEO currently screens at market cap $924.0M.
ECL currently screens at market cap $72.05B and trailing P/E 34.6. NEO currently screens at market cap $924.0M.
Not investment advice. Open the ECL and NEO stock pages for the full models.
Not investment advice.